CSIMarket


Lftd Partners Inc   (LIFD)
Other Ticker:  
 

Lftd Partners Inc

LIFD's Fundamental analysis








Looking into Lftd Partners Inc growth rates, revenue grew by 16.63 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 872

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Lftd Partners Inc 's net income grew by 45.85 % in III. Quarter 2023 year on year, above company average,

More on LIFD's Growth


Lftd Partners Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Lftd Partners Inc realized cash outflow of $ -0.08per share in trailing twelve-month period.
Company
13.36
PE TTM   
Industry
333.47
PE TTM    
Company's Price to Sales ratio is at 0.75.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.5.


More on LIFD's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 17.5
 Tangible Book Value (Per Share $) 1.02

Lftd Partners Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Lftd Partners Inc realized cash outflow of $ -0.08per share in trailing twelve-month period.
Company
13.36
PE TTM   
Industry
333.47
PE TTM    
Company's Price to Sales ratio is at 0.75.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.5.

Lftd Partners Inc Price to Book Ratio is at 0.95 lower than Indusry Avg. of 1312.2. and higher than S&P 500 Avg. of -2103.47

More on LIFD's Valuation

  Market Capitalization (Millions $) 37
  Shares Outstanding (Millions) 15
  Employees -
  Revenues (TTM) (Millions $) 49
  Net Income (TTM) (Millions $) 3
  Cash Flow (TTM) (Millions $) -1
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 17.5
  Tangible Book Value (Per Share $) 1.02

  Market Capitalization (Millions $) 37
  Shares Outstanding (Millions) 15
  Employees -
  Revenues (TTM) (Millions $) 49
  Net Income (TTM) (Millions $) 3
  Cash Flow (TTM) (Millions $) -1
  Capital Exp. (TTM) (Millions $) -1


    LIFD's Profitability Comparisons
Lftd Partners Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2023 to 5.03 % from 18.95 % in II. Quarter.

Lftd Partners Inc net profit margin of 4.71 % is currently ranking no. 54 in Major Pharmaceutical Preparations industry, ranking no. 143 in Healthcare sector and number 1899 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.3
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.57
  Asset Turnover Ratio (TTM) 1.12
  Inventory Turnover Ratio (TTM) 3.49



Lftd Partners Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2023 to 5.03 % from 18.95 % in II. Quarter.

Lftd Partners Inc net profit margin of 4.71 % is currently ranking no. 54 in Major Pharmaceutical Preparations industry, ranking no. 143 in Healthcare sector and number 1899 in S&P 500.

More on LIFD's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com